Researchers at University College London (UCL) have developed a test that accurately identified Parkinson’s disease up to seven years…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
Changes in how regions of the brain interact with each other, which occur during the surgical procedure for deep…
Taking levodopa, the mainstay of treatment for Parkinson’s disease, results in two key brain regions for movement strongly…
The use of medical cannabis in the U.S. has grown as more states legalize it, and programs listing Parkinson’s…
Lactulose — a synthetic (lab-made) sugar used to soften stools — may ease symptoms of constipation in people with…
Recognizing cognitive decline and low sex drive in people with Parkinson’s disease and depression could aid the early diagnosis…
Aside from easing motor symptoms of Parkinson’s disease, deep brain stimulation (DBS) may also slow disease progression by keeping…
Low to moderate doses of CAP-003, a gene therapy in the pipeline from Capsida Biotherapeutics, increased levels of glucocerebrosidase…
NE3107, now known as bezisterim, eased both motor and nonmotor symptoms when used in combination with a standard carbidopa/levodopa…
Genetic variations along with exposure to environmental factors, such as pesticides, may increase Parkinson’s disease in a sex-dependent manner,…